AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

CyberArk's Rally Could Pause Before Resuming Into Year-End

A key technical signal indicates that buyers of the cybersecurity company's shares again have become more aggressive in recent weeks.

Global Blood Therapeutics Is Poised to Rally Further in the Months Ahead

GBT is dedicated to discovering, developing, and commercializing ways to treat blood disorders.

Bullish Looking Jazz Pharmaceutical Gets a Boost From a Quant Buy Recommendation

Let's review the charts and indicators of this Dublin-based biopharmaceutical.

ZS Is Ready to Scale Up in Weeks Ahead

Zscaler has made a three-month pattern that can support higher prices in the near future.

Coupa Software Is Poised to Breakout of Its Chart Pattern One Way or the Other

Let's check out the charts of COUP and see which outcome looks most likely.

Amazon Looks Ready for Cyber Monday and Future Price Gains

The technical signs of the online giant are pointing its stock moving higher after an extended period of sideways action.

Autodesk Breaks Out to Merit New Price Target

Shares of the software company could trade sideways for a bit after their recent strong run, but a dip looks like an opportunity to buy.

Can DexCom Trade Still Higher or Did We Witness a Blow Off?

Let's check the charts and indicators before answering the $64,000 question.

FedEx Finally Looks Ready to Make Its Move to the Upside

Let's check out the charts before they get too busy delivering packages.

So Far, LRCX Shares Remain on the Lam

Lam Research can continue to be traded from the long side, as it continues its run upward.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight